VISCHER acted as legal counsel to MegaCAD on this transaction. MegaCAD GmbH has acquired Bausoft Informatik AG, a renowned Swiss software manufacturer specializing in building engineering...
You must be a Standard 1 Year member to access this content.
VISCHER advised ImmunOs Therapeutics AG on all legal issues related to the transaction. ImmunOs Therapeutics AG, a biopharmaceutical company leveraging its unique immune system modulating HLA-based...
You must be a Standard 1 Year member to access this content.
VISCHER acted as Swiss counsel to Santis Pharma in collaboration with lead counsel Archers Avocats. Santis Pharma, a Franco-Swiss laboratory company developing and marketing food supplements...
You must be a Standard 1 Year member to access this content.
VISCHER advised Haya Therapeutics SA on the Swiss legal aspects of the transaction. Cooley acted as lead counsel in this transaction. HAYA Therapeutics SA, a Swiss...
You must be a Standard 1 Year member to access this content.
VISCHER’s advised Genedata on the deal. Genedata AG, a leading provider of software solutions for biopharmaceutical R&D, has been acquired by Danaher Corporation (NYSE: DHR), a...
You must be a Standard 1 Year member to access this content.
VISCHER advised Mininavident AG on the deal. Mininavident AG, in Liestal, developer and manufacturer of the world’s smallest dynamic navigation system for dental implant placement, was...
You must be a Standard 1 Year member to access this content.
VISCHER acted as legal counsel to OCHSNER SPORT and DOSENBACH. OCHSNER SPORT and DOSENBACH concluded agreements with MIGROS according to which OCHSNER SPORT and DOSENBACH will...
You must be a Standard 1 Year member to access this content.
CMS advised ISS Facility Services AG while VISCHER acted for gammaRenax. ISS Facility Services AG acquires gammaRenax AG. gammaRenax is an accomplished quality provider of integral...
You must be a Standard 1 Year member to access this content.
VISCHER acted as legal counsel to BID Equity on this transaction. BID Equity acquires Realview AG, which develops and distributes software for the Swiss construction industry....
You must be a Standard 1 Year member to access this content.
VISCHER advised Ysios Capital and Kurma Partners. Memo Therapeutics AG, a late-stage biotech company developing a best-in-class BKV-neutralizing anti-body for BKV infection in kidney transplantation, raised...
You must be a Standard 1 Year member to access this content.
VISCHER advised narrowin GmbH on all aspects on this transaction. The German energy supplier EnBW enters into a partnership with narrowin GmbH, a Swiss cybersecurity start-up....
You must be a Standard 1 Year member to access this content.
VISCHER AG acted for Odne on the deal. Swiss dental startup Odne (former Lumendo) has raised USD 5.5m to fund the upcoming US market launch for...
You must be a Standard 1 Year member to access this content.
